Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-05-057998
Filing Date
2005-11-17
Accepted
2005-11-17 14:26:15
Documents
2
Period of Report
2005-11-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8287
2 POA DOCUMENT poa.txt EX-24.3_108999 3495
  Complete submission text file 0001209191-05-057998.txt   13602
Mailing Address
Business Address 21720-23RD DRIVE SE, SUITE 100 BOTHELL WA 98021 4256083000
NORTHWEST BIOTHERAPEUTICS INC (Issuer) CIK: 0001072379 (see all company filings)

EIN.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7600 WISCONSIN AVENUE SUITE 700 BETHESDA MD 20814
Business Address 7600 WISCONSIN AVENUE SUITE 700 BETHESDA MD 20814 (240) 497-4060
Toucan Partners, LLC (Reporting) CIK: 0001344441 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-33393 | Film No.: 051212237